The global market for Teriflunomide Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Teriflunomide tablets are a pyrimidine synthesis inhibitor indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease,and active secondary progressive disease, in adults.

North American market for Teriflunomide Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Teriflunomide Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Teriflunomide Tablets include Sanofi, Cisen Pharmaceutical, Nanjing Healthnice Pharmaceutical, CGeneTech (Suzhou, China), Mylan, Zydus, Accord Healthcare, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Teva, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Teriflunomide Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Teriflunomide Tablets.

The Teriflunomide Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Teriflunomide Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Teriflunomide Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Teriflunomide Tablets Market Report

Report Metric	Details
Report Name	Teriflunomide Tablets Market
Segment by Type	7mg per Tablet 14mg per Tablet
Segment by Application	Hospital and Clinic Pharmacy Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, Cisen Pharmaceutical, Nanjing Healthnice Pharmaceutical, CGeneTech (Suzhou, China), Mylan, Zydus, Accord Healthcare, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Teva, Camber Pharmaceuticals, Alembic, Apotex, Aurobindo Pharma, SOLA Pharmaceuticals, Sandoz, Viatris
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Teriflunomide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Teriflunomide Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Teriflunomide Tablets Market report?

Ans: The main players in the Teriflunomide Tablets Market are Sanofi, Cisen Pharmaceutical, Nanjing Healthnice Pharmaceutical, CGeneTech (Suzhou, China), Mylan, Zydus, Accord Healthcare, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Teva, Camber Pharmaceuticals, Alembic, Apotex, Aurobindo Pharma, SOLA Pharmaceuticals, Sandoz, Viatris

What are the Application segmentation covered in the Teriflunomide Tablets Market report?

Ans: The Applications covered in the Teriflunomide Tablets Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Teriflunomide Tablets Market report?

Ans: The Types covered in the Teriflunomide Tablets Market report are 7mg per Tablet, 14mg per Tablet

1 Teriflunomide Tablets Market Overview

1.1 Product Definition

1.2 Teriflunomide Tablets by Type

1.2.1 Global Teriflunomide Tablets Market Value Comparison by Type (2024 VS 2031)

1.2.2 7mg per Tablet

1.2.3 14mg per Tablet

1.3 Teriflunomide Tablets by Application

1.3.1 Global Teriflunomide Tablets Market Value by Application (2024 VS 2031)

1.3.2 Hospital and Clinic

1.3.3 Pharmacy

1.3.4 Other

1.4 Global Teriflunomide Tablets Market Size Estimates and Forecasts

1.4.1 Global Teriflunomide Tablets Revenue 2020-2031

1.4.2 Global Teriflunomide Tablets Sales 2020-2031

1.4.3 Global Teriflunomide Tablets Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Teriflunomide Tablets Market Competition by Manufacturers

2.1 Global Teriflunomide Tablets Sales Market Share by Manufacturers (2020-2025)

2.2 Global Teriflunomide Tablets Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Teriflunomide Tablets Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Teriflunomide Tablets, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Teriflunomide Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Teriflunomide Tablets, Product Type & Application

2.7 Global Key Manufacturers of Teriflunomide Tablets, Date of Enter into This Industry

2.8 Global Teriflunomide Tablets Market Competitive Situation and Trends

2.8.1 Global Teriflunomide Tablets Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Teriflunomide Tablets Players Market Share by Revenue

2.8.3 Global Teriflunomide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Teriflunomide Tablets Market Scenario by Region

3.1 Global Teriflunomide Tablets Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Teriflunomide Tablets Sales by Region: 2020-2031

3.2.1 Global Teriflunomide Tablets Sales by Region: 2020-2025

3.2.2 Global Teriflunomide Tablets Sales by Region: 2026-2031

3.3 Global Teriflunomide Tablets Revenue by Region: 2020-2031

3.3.1 Global Teriflunomide Tablets Revenue by Region: 2020-2025

3.3.2 Global Teriflunomide Tablets Revenue by Region: 2026-2031

3.4 North America Teriflunomide Tablets Market Facts & Figures by Country

3.4.1 North America Teriflunomide Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Teriflunomide Tablets Sales by Country (2020-2031)

3.4.3 North America Teriflunomide Tablets Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Teriflunomide Tablets Market Facts & Figures by Country

3.5.1 Europe Teriflunomide Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Teriflunomide Tablets Sales by Country (2020-2031)

3.5.3 Europe Teriflunomide Tablets Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Teriflunomide Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Teriflunomide Tablets Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Teriflunomide Tablets Sales by Region (2020-2031)

3.6.3 Asia Pacific Teriflunomide Tablets Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Teriflunomide Tablets Market Facts & Figures by Country

3.7.1 Latin America Teriflunomide Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Teriflunomide Tablets Sales by Country (2020-2031)

3.7.3 Latin America Teriflunomide Tablets Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Teriflunomide Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Teriflunomide Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Teriflunomide Tablets Sales by Country (2020-2031)

3.8.3 Middle East and Africa Teriflunomide Tablets Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Teriflunomide Tablets Sales by Type (2020-2031)

4.1.1 Global Teriflunomide Tablets Sales by Type (2020-2025)

4.1.2 Global Teriflunomide Tablets Sales by Type (2026-2031)

4.1.3 Global Teriflunomide Tablets Sales Market Share by Type (2020-2031)

4.2 Global Teriflunomide Tablets Revenue by Type (2020-2031)

4.2.1 Global Teriflunomide Tablets Revenue by Type (2020-2025)

4.2.2 Global Teriflunomide Tablets Revenue by Type (2026-2031)

4.2.3 Global Teriflunomide Tablets Revenue Market Share by Type (2020-2031)

4.3 Global Teriflunomide Tablets Price by Type (2020-2031)

5 Segment by Application

5.1 Global Teriflunomide Tablets Sales by Application (2020-2031)

5.1.1 Global Teriflunomide Tablets Sales by Application (2020-2025)

5.1.2 Global Teriflunomide Tablets Sales by Application (2026-2031)

5.1.3 Global Teriflunomide Tablets Sales Market Share by Application (2020-2031)

5.2 Global Teriflunomide Tablets Revenue by Application (2020-2031)

5.2.1 Global Teriflunomide Tablets Revenue by Application (2020-2025)

5.2.2 Global Teriflunomide Tablets Revenue by Application (2026-2031)

5.2.3 Global Teriflunomide Tablets Revenue Market Share by Application (2020-2031)

5.3 Global Teriflunomide Tablets Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Company Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sanofi Teriflunomide Tablets Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 Cisen Pharmaceutical

6.2.1 Cisen Pharmaceutical Company Information

6.2.2 Cisen Pharmaceutical Description and Business Overview

6.2.3 Cisen Pharmaceutical Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Cisen Pharmaceutical Teriflunomide Tablets Product Portfolio

6.2.5 Cisen Pharmaceutical Recent Developments/Updates

6.3 Nanjing Healthnice Pharmaceutical

6.3.1 Nanjing Healthnice Pharmaceutical Company Information

6.3.2 Nanjing Healthnice Pharmaceutical Description and Business Overview

6.3.3 Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Product Portfolio

6.3.5 Nanjing Healthnice Pharmaceutical Recent Developments/Updates

6.4 CGeneTech (Suzhou, China)

6.4.1 CGeneTech (Suzhou, China) Company Information

6.4.2 CGeneTech (Suzhou, China) Description and Business Overview

6.4.3 CGeneTech (Suzhou, China) Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.4.4 CGeneTech (Suzhou, China) Teriflunomide Tablets Product Portfolio

6.4.5 CGeneTech (Suzhou, China) Recent Developments/Updates

6.5 Mylan

6.5.1 Mylan Company Information

6.5.2 Mylan Description and Business Overview

6.5.3 Mylan Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Mylan Teriflunomide Tablets Product Portfolio

6.5.5 Mylan Recent Developments/Updates

6.6 Zydus

6.6.1 Zydus Company Information

6.6.2 Zydus Description and Business Overview

6.6.3 Zydus Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Zydus Teriflunomide Tablets Product Portfolio

6.6.5 Zydus Recent Developments/Updates

6.7 Accord Healthcare

6.7.1 Accord Healthcare Company Information

6.7.2 Accord Healthcare Description and Business Overview

6.7.3 Accord Healthcare Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Accord Healthcare Teriflunomide Tablets Product Portfolio

6.7.5 Accord Healthcare Recent Developments/Updates

6.8 Dr. Reddy's Laboratories

6.8.1 Dr. Reddy's Laboratories Company Information

6.8.2 Dr. Reddy's Laboratories Description and Business Overview

6.8.3 Dr. Reddy's Laboratories Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Dr. Reddy's Laboratories Teriflunomide Tablets Product Portfolio

6.8.5 Dr. Reddy's Laboratories Recent Developments/Updates

6.9 Glenmark Pharmaceuticals

6.9.1 Glenmark Pharmaceuticals Company Information

6.9.2 Glenmark Pharmaceuticals Description and Business Overview

6.9.3 Glenmark Pharmaceuticals Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Glenmark Pharmaceuticals Teriflunomide Tablets Product Portfolio

6.9.5 Glenmark Pharmaceuticals Recent Developments/Updates

6.10 Teva

6.10.1 Teva Company Information

6.10.2 Teva Description and Business Overview

6.10.3 Teva Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Teva Teriflunomide Tablets Product Portfolio

6.10.5 Teva Recent Developments/Updates

6.11 Camber Pharmaceuticals

6.11.1 Camber Pharmaceuticals Company Information

6.11.2 Camber Pharmaceuticals Description and Business Overview

6.11.3 Camber Pharmaceuticals Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Camber Pharmaceuticals Teriflunomide Tablets Product Portfolio

6.11.5 Camber Pharmaceuticals Recent Developments/Updates

6.12 Alembic

6.12.1 Alembic Company Information

6.12.2 Alembic Description and Business Overview

6.12.3 Alembic Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Alembic Teriflunomide Tablets Product Portfolio

6.12.5 Alembic Recent Developments/Updates

6.13 Apotex

6.13.1 Apotex Company Information

6.13.2 Apotex Description and Business Overview

6.13.3 Apotex Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Apotex Teriflunomide Tablets Product Portfolio

6.13.5 Apotex Recent Developments/Updates

6.14 Aurobindo Pharma

6.14.1 Aurobindo Pharma Company Information

6.14.2 Aurobindo Pharma Description and Business Overview

6.14.3 Aurobindo Pharma Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Aurobindo Pharma Teriflunomide Tablets Product Portfolio

6.14.5 Aurobindo Pharma Recent Developments/Updates

6.15 SOLA Pharmaceuticals

6.15.1 SOLA Pharmaceuticals Company Information

6.15.2 SOLA Pharmaceuticals Description and Business Overview

6.15.3 SOLA Pharmaceuticals Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.15.4 SOLA Pharmaceuticals Teriflunomide Tablets Product Portfolio

6.15.5 SOLA Pharmaceuticals Recent Developments/Updates

6.16 Sandoz

6.16.1 Sandoz Company Information

6.16.2 Sandoz Description and Business Overview

6.16.3 Sandoz Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Sandoz Teriflunomide Tablets Product Portfolio

6.16.5 Sandoz Recent Developments/Updates

6.17 Viatris

6.17.1 Viatris Company Information

6.17.2 Viatris Description and Business Overview

6.17.3 Viatris Teriflunomide Tablets Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Viatris Teriflunomide Tablets Product Portfolio

6.17.5 Viatris Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Teriflunomide Tablets Industry Chain Analysis

7.2 Teriflunomide Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Teriflunomide Tablets Production Mode & Process Analysis

7.4 Teriflunomide Tablets Sales and Marketing

7.4.1 Teriflunomide Tablets Sales Channels

7.4.2 Teriflunomide Tablets Distributors

7.5 Teriflunomide Tablets Customer Analysis

8 Teriflunomide Tablets Market Dynamics

8.1 Teriflunomide Tablets Industry Trends

8.2 Teriflunomide Tablets Market Drivers

8.3 Teriflunomide Tablets Market Challenges

8.4 Teriflunomide Tablets Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Sanofi

Cisen Pharmaceutical

Nanjing Healthnice Pharmaceutical

CGeneTech (Suzhou, China)

Mylan NV

Zydus

Accord Healthcare

Dr. Reddy’s Laboratories

Glenmark Pharmaceuticals

TEVA

Camber Pharmaceuticals

List of Tables

Table 1. Global Teriflunomide Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Teriflunomide Tablets Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Teriflunomide Tablets Market Competitive Situation by Manufacturers in 2024

Table 4. Global Teriflunomide Tablets Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Teriflunomide Tablets Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Teriflunomide Tablets Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Teriflunomide Tablets Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Teriflunomide Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Teriflunomide Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Teriflunomide Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Teriflunomide Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Teriflunomide Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Teriflunomide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Teriflunomide Tablets as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Teriflunomide Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Teriflunomide Tablets Sales by Region (2020-2025) & (K Units)

Table 18. Global Teriflunomide Tablets Sales Market Share by Region (2020-2025)

Table 19. Global Teriflunomide Tablets Sales by Region (2026-2031) & (K Units)

Table 20. Global Teriflunomide Tablets Sales Market Share by Region (2026-2031)

Table 21. Global Teriflunomide Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Teriflunomide Tablets Revenue Market Share by Region (2020-2025)

Table 23. Global Teriflunomide Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Teriflunomide Tablets Revenue Market Share by Region (2026-2031)

Table 25. North America Teriflunomide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Teriflunomide Tablets Sales by Country (2020-2025) & (K Units)

Table 27. North America Teriflunomide Tablets Sales by Country (2026-2031) & (K Units)

Table 28. North America Teriflunomide Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Teriflunomide Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Teriflunomide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Teriflunomide Tablets Sales by Country (2020-2025) & (K Units)

Table 32. Europe Teriflunomide Tablets Sales by Country (2026-2031) & (K Units)

Table 33. Europe Teriflunomide Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Teriflunomide Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Teriflunomide Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Teriflunomide Tablets Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Teriflunomide Tablets Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Teriflunomide Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Teriflunomide Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Teriflunomide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Teriflunomide Tablets Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Teriflunomide Tablets Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Teriflunomide Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Teriflunomide Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Teriflunomide Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Teriflunomide Tablets Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Teriflunomide Tablets Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Teriflunomide Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Teriflunomide Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Teriflunomide Tablets Sales (K Units) by Type (2020-2025)

Table 51. Global Teriflunomide Tablets Sales (K Units) by Type (2026-2031)

Table 52. Global Teriflunomide Tablets Sales Market Share by Type (2020-2025)

Table 53. Global Teriflunomide Tablets Sales Market Share by Type (2026-2031)

Table 54. Global Teriflunomide Tablets Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Teriflunomide Tablets Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Teriflunomide Tablets Revenue Market Share by Type (2020-2025)

Table 57. Global Teriflunomide Tablets Revenue Market Share by Type (2026-2031)

Table 58. Global Teriflunomide Tablets Price (US$/Unit) by Type (2020-2025)

Table 59. Global Teriflunomide Tablets Price (US$/Unit) by Type (2026-2031)

Table 60. Global Teriflunomide Tablets Sales (K Units) by Application (2020-2025)

Table 61. Global Teriflunomide Tablets Sales (K Units) by Application (2026-2031)

Table 62. Global Teriflunomide Tablets Sales Market Share by Application (2020-2025)

Table 63. Global Teriflunomide Tablets Sales Market Share by Application (2026-2031)

Table 64. Global Teriflunomide Tablets Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Teriflunomide Tablets Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Teriflunomide Tablets Revenue Market Share by Application (2020-2025)

Table 67. Global Teriflunomide Tablets Revenue Market Share by Application (2026-2031)

Table 68. Global Teriflunomide Tablets Price (US$/Unit) by Application (2020-2025)

Table 69. Global Teriflunomide Tablets Price (US$/Unit) by Application (2026-2031)

Table 70. Sanofi Company Information

Table 71. Sanofi Description and Business Overview

Table 72. Sanofi Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Sanofi Teriflunomide Tablets Product

Table 74. Sanofi Recent Developments/Updates

Table 75. Cisen Pharmaceutical Company Information

Table 76. Cisen Pharmaceutical Description and Business Overview

Table 77. Cisen Pharmaceutical Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Cisen Pharmaceutical Teriflunomide Tablets Product

Table 79. Cisen Pharmaceutical Recent Developments/Updates

Table 80. Nanjing Healthnice Pharmaceutical Company Information

Table 81. Nanjing Healthnice Pharmaceutical Description and Business Overview

Table 82. Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Product

Table 84. Nanjing Healthnice Pharmaceutical Recent Developments/Updates

Table 85. CGeneTech (Suzhou, China) Company Information

Table 86. CGeneTech (Suzhou, China) Description and Business Overview

Table 87. CGeneTech (Suzhou, China) Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. CGeneTech (Suzhou, China) Teriflunomide Tablets Product

Table 89. CGeneTech (Suzhou, China) Recent Developments/Updates

Table 90. Mylan Company Information

Table 91. Mylan Description and Business Overview

Table 92. Mylan Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Mylan Teriflunomide Tablets Product

Table 94. Mylan Recent Developments/Updates

Table 95. Zydus Company Information

Table 96. Zydus Description and Business Overview

Table 97. Zydus Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Zydus Teriflunomide Tablets Product

Table 99. Zydus Recent Developments/Updates

Table 100. Accord Healthcare Company Information

Table 101. Accord Healthcare Description and Business Overview

Table 102. Accord Healthcare Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Accord Healthcare Teriflunomide Tablets Product

Table 104. Accord Healthcare Recent Developments/Updates

Table 105. Dr. Reddy's Laboratories Company Information

Table 106. Dr. Reddy's Laboratories Description and Business Overview

Table 107. Dr. Reddy's Laboratories Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Dr. Reddy's Laboratories Teriflunomide Tablets Product

Table 109. Dr. Reddy's Laboratories Recent Developments/Updates

Table 110. Glenmark Pharmaceuticals Company Information

Table 111. Glenmark Pharmaceuticals Description and Business Overview

Table 112. Glenmark Pharmaceuticals Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Glenmark Pharmaceuticals Teriflunomide Tablets Product

Table 114. Glenmark Pharmaceuticals Recent Developments/Updates

Table 115. Teva Company Information

Table 116. Teva Description and Business Overview

Table 117. Teva Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Teva Teriflunomide Tablets Product

Table 119. Teva Recent Developments/Updates

Table 120. Camber Pharmaceuticals Company Information

Table 121. Camber Pharmaceuticals Description and Business Overview

Table 122. Camber Pharmaceuticals Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Camber Pharmaceuticals Teriflunomide Tablets Product

Table 124. Camber Pharmaceuticals Recent Developments/Updates

Table 125. Alembic Company Information

Table 126. Alembic Description and Business Overview

Table 127. Alembic Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Alembic Teriflunomide Tablets Product

Table 129. Alembic Recent Developments/Updates

Table 130. Apotex Company Information

Table 131. Apotex Description and Business Overview

Table 132. Apotex Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Apotex Teriflunomide Tablets Product

Table 134. Apotex Recent Developments/Updates

Table 135. Aurobindo Pharma Company Information

Table 136. Aurobindo Pharma Description and Business Overview

Table 137. Aurobindo Pharma Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Aurobindo Pharma Teriflunomide Tablets Product

Table 139. Aurobindo Pharma Recent Developments/Updates

Table 140. SOLA Pharmaceuticals Company Information

Table 141. SOLA Pharmaceuticals Description and Business Overview

Table 142. SOLA Pharmaceuticals Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. SOLA Pharmaceuticals Teriflunomide Tablets Product

Table 144. SOLA Pharmaceuticals Recent Developments/Updates

Table 145. Sandoz Company Information

Table 146. Sandoz Description and Business Overview

Table 147. Sandoz Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. Sandoz Teriflunomide Tablets Product

Table 149. Sandoz Recent Developments/Updates

Table 150. Viatris Company Information

Table 151. Viatris Description and Business Overview

Table 152. Viatris Teriflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 153. Viatris Teriflunomide Tablets Product

Table 154. Viatris Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Teriflunomide Tablets Distributors List

Table 158. Teriflunomide Tablets Customers List

Table 159. Teriflunomide Tablets Market Trends

Table 160. Teriflunomide Tablets Market Drivers

Table 161. Teriflunomide Tablets Market Challenges

Table 162. Teriflunomide Tablets Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Teriflunomide Tablets

Figure 2. Global Teriflunomide Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Teriflunomide Tablets Market Share by Type: 2024 & 2031

Figure 4. 7mg per Tablet Product Picture

Figure 5. 14mg per Tablet Product Picture

Figure 6. Global Teriflunomide Tablets Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Teriflunomide Tablets Market Share by Application: 2024 & 2031

Figure 8. Hospital and Clinic

Figure 9. Pharmacy

Figure 10. Other

Figure 11. Global Teriflunomide Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Teriflunomide Tablets Market Size (2020-2031) & (US$ Million)

Figure 13. Global Teriflunomide Tablets Sales (2020-2031) & (K Units)

Figure 14. Global Teriflunomide Tablets Average Price (US$/Unit) & (2020-2031)

Figure 15. Teriflunomide Tablets Report Years Considered

Figure 16. Teriflunomide Tablets Sales Share by Manufacturers in 2024

Figure 17. Global Teriflunomide Tablets Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Teriflunomide Tablets Players: Market Share by Revenue in Teriflunomide Tablets in 2024

Figure 19. Teriflunomide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Teriflunomide Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Teriflunomide Tablets Sales Market Share by Country (2020-2031)

Figure 22. North America Teriflunomide Tablets Revenue Market Share by Country (2020-2031)

Figure 23. United States Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Teriflunomide Tablets Sales Market Share by Country (2020-2031)

Figure 26. Europe Teriflunomide Tablets Revenue Market Share by Country (2020-2031)

Figure 27. Germany Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Teriflunomide Tablets Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Teriflunomide Tablets Revenue Market Share by Region (2020-2031)

Figure 34. China Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Teriflunomide Tablets Sales Market Share by Country (2020-2031)

Figure 42. Latin America Teriflunomide Tablets Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Teriflunomide Tablets Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Teriflunomide Tablets Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Teriflunomide Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Teriflunomide Tablets by Type (2020-2031)

Figure 53. Global Revenue Market Share of Teriflunomide Tablets by Type (2020-2031)

Figure 54. Global Teriflunomide Tablets Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Teriflunomide Tablets by Application (2020-2031)

Figure 56. Global Revenue Market Share of Teriflunomide Tablets by Application (2020-2031)

Figure 57. Global Teriflunomide Tablets Price (US$/Unit) by Application (2020-2031)

Figure 58. Teriflunomide Tablets Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions